Master Framework For Relapse or Refractory Acute Myeloid Leukemia
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is an observational (non-interventional), prospective, cohort study that will collects data from patients diagnosed with relapsed or refractory acute myeloid leukemia afferent to the participanting clinical sites
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rozpoznanie ostrej białaczki mieloidalnej potwierdzone wg aktualnych wytycznych WHO lub ICC
- •Choroba, którą wcześniejsze leczenie nie zatrzymało - nawrót, brak odpowiedzi na leczenie lub progresja
- •Pacjent lub jego reprezentant prawny chętnie wyraża zgodę na uczestnictwo w badaniu
✗ Disqualifies
- •Pacjenci już uczestniczący w badaniach klinicznych mogą być włączeni, chyba że protokół badania stanowi inaczej
Simplified criteria — AI translation
Trial details
- Minimum age
- 6 Years
- Last updated (source)
- August 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (40)
University Hospital Aachen
Aachen, Germany
University Hospital Greifswald
Greifswald, Germany
University Hospital Halle
Halle, Germany
University Hospital of Rostock
Rostock, Germany
Policlinico Sant'Orsola-Malpighi
Bologna, Italy
Ospedale "A. Perrino"
Brindisi, Italy
ASST Spedali Civili
Brescia, Italy
Azienda Ospedaliera S. Croce e Carle
Cuneo, Italy
Ospedale Valduce
Como, Italy
ASST Cremona
Cremona, Italy
AOU Universitaria Arcispedale Sant'Anna
Ferrara, Italy
IRCCS Ospedale Policlinico San Martino
Genova, Italy
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Italy
ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy
Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello
Palermo, Italy
Presidio Ospedaliero "Santo Spirito"
Pescara, Italy
Ospedale Santa Maria della Misericordia
Perugia, Italy
Ospedale Santa Maria delle Croci
Ravenna, Italy
Fondazione Policlinico Tor Vergata
Roma, Italy
Policlinico Umberto I
Roma, Italy
Policlinico Universitario Fondazione Agostino Gemelli
Roma, Italy
Ospedale Sant'Andrea
Roma, Italy
Ospedale infermi di Rimini
Rimini, Italy
AOU San Giovanni di Dio e Ruggi d'Aragona
Salerno, Italy
AOU Città della Salute e della Scienza di Torino
Torino, Italy
AO Ordine Mauriziano
Torino, Italy
IOV Istituto Oncologico Veneto
Castelfranco Veneto, Italy
ASST Valle Olona
Busto Arsizio, Italy
Azienda Ospedaliero Universitaria Delle Marche
Ancona, Italy
AOU Careggi
Florence, Italy
IRST Istituto Romagnolo per lo Studio dei Tumori Dino Amadori
Meldola, Italy
Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli
Naples, Italy
Azienda Ospeldaliera Universitaria Federico II
Naples, Italy
AOU Maggiore della Carità
Novara, Italy
Azienda Ospedale-Università Padova
Padova, Italy
Ospedale San Bortolo
Vicenza, Italy
The Hospital of Lithuanian University of Health Sciences Kauno Klinikos
Kaunas, Lithuania
University Clinical Center in Gdańsk
Gdansk, Poland
Fundeni Clinical Institute
Bucharest, Romania
University Hospital La Fe
Valencia, Spain
Trial contact
Oriana Nanni
Impact-aml coord Impact-aml coord
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.